Studies. FS, AS, and AM: DFTs and PK studies. MH: references and manuscript formatting. SA: manuscript revision.Information availability statementThe original contributions presented within the study are incorporated within the article/Supplementary Material further inquiries can be directed for the corresponding author.Acknowledgments Ethics statementThe Animals utilised in current study had been beneath the Institutional Animal Care and Use Committee. Written informed consent was The authors would like to thank the Deanship of Scientific Research at Shaqra University for supporting this function. We would like to thank Editage (editage) for English language editing.Frontiers in Pharmacologyfrontiersin.orgShafique et al.ten.3389/fphar.2023.Conflict of interestThe authors declare that the research was performed inside the absence of any commercial or monetary relationships that might be construed as a possible conflict of interest.organizations, or these with the publisher, the editors along with the reviewers. Any item that may possibly be evaluated in this write-up, or claim that may perhaps be created by its manufacturer, is not guaranteed or endorsed by the publisher.Publisher’s noteAll claims expressed within this short article are solely these of your authors and don’t necessarily represent these of their affiliatedSupplementary materialThe Supplementary Material for this article is usually found on line at: frontiersin.org/articles/10.3389/fphar.2023.1025013/ fullsupplementary-material
virusesArticleThe Novel Locating of Dynamic Change in eGFR As much as 1 Year following End of Therapy in HCV-Infected Patients Receiving Sofosbuvir and VelpatasvirCheng-Kun Wu 1, , Li-Wei Chen 2, , Te-Sheng Chang three , Shui-Yi Tung 3 , Chun-Yen Lin 4 , Chao-Hung Hung 1 , Sheng-Nan Lu 1 , Chih-Lang Lin two , Chien-Hung Chen 1 , Chao-Wei Hsu 4, , , Tsung-Hui Hu 1, , and I-Shyan SheenCitation: Wu, C.-K.; Chen, L.-W.; Chang, T.-S.; Tung, S.-Y.; Lin, C.-Y.; Hung, C.-H.; Lu, S.-N.; Lin, C.-L.; Chen, C.-H.; Hsu, C.-W.; et al. The Novel Locating of Dynamic Change in eGFR Up to A single Year right after End of Treatment in HCV-Infected Individuals Receiving Sofosbuvir and Velpatasvir. Viruses 2022, 14, 362. doi.org/10.3390/v14020362 Academic Editors: Pietro Andreone and Stefano Brillanti Received: 18 January 2022 Accepted: 8 February 2022 Published: ten February 2022 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan; aasavage.Lumican/LUM Protein web tw@yahoo.Envelope glycoprotein gp120, HIV (Q9DKG6, HEK293, His) tw (C.PMID:23667820 -K.W.); [email protected] (C.-H.H.); [email protected] (S.-N.L.); [email protected] (C.-H.C.) Division of Hepato-Gastroenterology, Division of Internal Medicine, Keelung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung 20420, Taiwan; [email protected] (L.-W.C.); [email protected] (C.-L.L.) Division of Hepato-Gastroenterology, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chiayi 613016, Taiwan; [email protected] (T.-S.C.); [email protected] (S.-Y.T.) Division of Hepato-Gastroenterology, Division of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Linkou 333423, Taiwan; chunyenlin@gmail (C.-Y.L.); happy95kevin@gmail (I.-S.S.) Correspondence: [email protected] (C.-W.H.); [email protected] (T.-H.H.); Tel.: +886-7-.